Letter regarding article by Ridker et al, "Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?"

Circulation. 2004 Dec 14;110(24):e532. doi: 10.1161/01.CIR.0000149807.32506.F4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • C-Reactive Protein / analysis*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / complications*
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors

Substances

  • C-Reactive Protein